Can you provide the last earnings date for AURINIA PHARMACEUTICALS INC?
AURINIA PHARMACEUTICALS INC (AUPH) last reported earnings on 2/26/2026.
AURINIA PHARMACEUTICALS INC (AUPH) Earnings History & Surprises
NASDAQ:AUPH • CA05156V1022
Current stock price
14.6 USD
+0.23 (+1.6%)
At close:
14.65 USD
+0.05 (+0.34%)
After Hours:
AUPH Earnings overview
Past quarterly earnings results for AURINIA PHARMACEUTICALS INC (AUPH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.20
- Revenue Estimate
- 77.592M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.26
- EPS Surprise
- 17.65%
- Revenue Surprise
- 1.01%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.26 | 0.22 | 17.65% | 2,500.00% | 77.114M | 76.342M | 1.01% | 28.81% |
| Q3 2025 | 0.23 | 0.16 | 40.93% | 130.00% | 73.468M | 68.767M | 6.84% | 8.41% |
| Q2 2025 | 0.16 | 0.15 | 6.95% | 1,500.00% | 70.008M | 64.971M | 7.75% | 22.41% |
| Q1 2025 | 0.16 | 0.10 | 56.86% | 633.33% | 62.465M | 62.766M | -0.48% | 24.18% |
| Q4 2024 | 0.01 | -0.02 | 161.27% | 105.26% | 59.867M | 61.143M | -2.09% | 32.76% |
| Q3 2024 | 0.10 | 0.02 | 553.59% | 211.11% | 67.771M | 58.847M | 15.16% | 24.32% |
| Q2 2024 | 0.01 | 0.01 | 17.69% | 112.50% | 57.192M | 56.156M | 1.84% | 37.83% |
| Q1 2024 | -0.03 | -0.14 | 78.48% | 83.33% | 50.303M | 48.403M | 3.93% | 46.19% |
| Q4 2023 | -0.19 | -0.17 | -14.05% | -5.56% | 45.095M | 45.214M | -0.26% | 58.56% |
| Q3 2023 | -0.09 | -0.17 | 47.21% | -50.00% | 54.515M | 39.275M | 38.80% | -2.27% |
| Q2 2023 | -0.08 | -0.19 | 57.22% | 68.00% | 41.494M | 38.91M | 6.64% | 47.19% |
| Q1 2023 | -0.18 | -0.23 | 20.30% | 33.33% | 34.409M | 28.432M | 21.02% | 59.08% |
| Q4 2022 | -0.18 | -0.28 | 35.33% | 28.00% | 28.44M | 28.335M | 0.37% | 21.54% |
| Q3 2022 | -0.06 | -0.17 | 65.10% | 84.62% | 55.78M | 36.913M | 51.11% | 280.23% |
| Q2 2022 | -0.25 | -0.23 | -9.75% | 32.43% | 28.19M | 27.685M | 1.82% | 325.83% |
| Q1 2022 | -0.27 | -0.27 | 0.91% | 32.50% | 21.63M | 20.158M | 7.30% | 2,276.92% |
| Q4 2021 | -0.25 | -0.27 | 8.74% | -400.00% | 23.4M | 22.435M | 4.30% | -53.23% |
| Q3 2021 | -0.39 | -0.34 | -14.87% | -39.29% | 14.67M | 14.156M | 3.63% | 48,800.00% |
| Q2 2021 | -0.37 | -0.37 | 0.42% | -42.31% | 6.62M | 4.786M | 38.32% | 21,966.67% |
| Q1 2021 | -0.40 | -0.37 | -7.44% | -166.67% | 910K | 3.229M | -71.82% | 2,933.33% |
| Q4 2020 | -0.05 | -0.25 | 79.93% | - | 50.03M | 30.6K | 163,396.73% | - |
| Q3 2020 | -0.28 | -0.24 | -17.44% | - | 30K | 31.447K | -4.60% | - |
| Q2 2020 | -0.26 | -0.24 | -10.29% | - | 30K | 34.343K | -12.65% | - |
| Q1 2020 | -0.15 | -0.27 | 45.02% | - | 30K | 37.74K | -20.51% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
30.60%
Max EPS beat (4)
56.86%
Min EPS beat (4)
6.95%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
3.78%
Max Revenue beat (4)
7.75%
Min Revenue beat (4)
-0.48%
Analysis
In the last 4 quarters, AUPH has consistently beaten EPS estimates in all releases
AUPH has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AUPH has beaten the EPS estimates by 30.6% on average.
In the last 4 quarters, AUPH has beaten the revenue estimates by 3.8% on average.
Related analysis
AURINIA PHARMACEUTICALS INC / AUPH Earnings FAQ
Did AURINIA PHARMACEUTICALS INC (AUPH) beat earnings estimates last quarter?
AURINIA PHARMACEUTICALS INC (AUPH) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often AURINIA PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, AURINIA PHARMACEUTICALS INC (AUPH) has beaten EPS estimates in 4 out of 4 releases.